SALIX PHARMACEUTICALS INC's ticker is SLXP and the CUSIP is 795435106. A total of 251 filers reported holding SALIX PHARMACEUTICALS INC in Q3 2013. The put-call ratio across all filers is 0.72 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2015 | $9,730,000 | +48.4% | 56,301 | -1.3% | 0.01% | +44.4% |
Q4 2014 | $6,556,000 | +21.3% | 57,037 | +64.9% | 0.01% | +12.5% |
Q3 2014 | $5,405,000 | -25.3% | 34,593 | -41.0% | 0.01% | -27.3% |
Q2 2014 | $7,235,000 | +2034.2% | 58,653 | +1693.7% | 0.01% | +1000.0% |
Q1 2014 | $339,000 | -50.9% | 3,270 | -57.4% | 0.00% | 0.0% |
Q4 2013 | $691,000 | +33.9% | 7,679 | -0.4% | 0.00% | 0.0% |
Q3 2013 | $516,000 | +102.4% | 7,711 | +100.0% | 0.00% | 0.0% |
Q2 2013 | $255,000 | – | 3,856 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Consonance Capital Management LP | 467,943 | $30,954,000 | 11.01% |
TANG CAPITAL MANAGEMENT LLC | 300,000 | $19,845,000 | 7.82% |
OAK RIDGE INVESTMENTS LLC | 1,382,895 | $91,478,000 | 2.87% |
SECTOR GAMMA AS | 147,001 | $9,724,000 | 2.84% |
Credo Capital Management, LLC | 38,869 | $2,571,000 | 1.98% |
Cardinal Capital Management | 48,226 | $3,190,000 | 1.89% |
ZEVENBERGEN CAPITAL INVESTMENTS LLC | 626,800 | $41,463,000 | 1.68% |
HERNDON CAPITAL MANAGEMENT LLC | 1,284,472 | $84,967,823,000 | 1.27% |
CATAPULT CAPITAL MANAGEMENT LLC | 45,000 | $2,977,000 | 1.24% |
Pier Capital, LLC | 108,556 | $7,181,000 | 1.10% |